Literature DB >> 32471314

Lancemaside A Isolated from the Root of Codonopsis lanceolata Inhibits Ovarian Cancer Cell Invasion via the Reactive Oxygen Species (ROS)-Mediated p38 Pathway.

Ji-Hye Ahn1,2,3, Dae Sik Jang4, Jung-Hye Choi1,3.   

Abstract

Codonopsis lanceolata roots have been widely used in Korean cuisine and traditional medicine. This study aimed to investigate the antimetastatic effects of lancemaside A, a major triterpenoid saponin, isolated from the roots of C. lanceolata, in human ovarian cancer cells. Lancemaside A significantly suppressed the migration and invasion and the expression of matrix metalloproteinases (MMPs)-2 and -9 in ovarian cancer A2780 and SKOV3 cells. Treatment with lancemaside A generated reactive oxygen species (ROS) in ovarian cancer cells. However, treatment with anti-oxidant N-acetyl-L-cysteine (NAC) significantly negated the anti-invasive activity of lancemaside A. Additionally, lancemaside A activated p38 MAP kinase, which is mediated by ROS generation. This is the first study, to our knowledge, to reveal that lancemaside A isolated from the roots of C. lanceolata exerts antimetastatic activity through inhibition of MMP expression and cancer cell invasion via activation of the ROS-mediated p38 pathway.

Entities:  

Keywords:  Codonopsis lanceolata; Invasion; Lancemaside A; Ovarian Cancer; Reactive Oxygen Species; p38

Year:  2020        PMID: 32471314     DOI: 10.1142/S0192415X20500494

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Using network pharmacology approaches to identify treatment mechanisms for codonopsis in esophageal cancer.

Authors:  Yuan Tian; Liang Tang
Journal:  Int J Clin Exp Pathol       Date:  2022-02-15

2.  Citromycin Isolated from the Antarctic Marine-Derived Fungi, Sporothrix sp., Inhibits Ovarian Cancer Cell Invasion via Suppression of ERK Signaling.

Authors:  He Yun Choi; Ji-Hye Ahn; Haeun Kwon; Joung Han Yim; Dongho Lee; Jung-Hye Choi
Journal:  Mar Drugs       Date:  2022-04-20       Impact factor: 6.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.